The physiology of cardiovascular disease and innovative liposomal platforms for therapy
Guillermo U Ruiz-Esparza,1,3 Jose H Flores-Arredondo,2 Victor Segura-Ibarra,3 Guillermo Torre-Amione,2,3 Mauro Ferrari,1 Elvin Blanco,1,* Rita E Serda1,3,* 1Methodist Hospital Research Institute, 2Methodist DeBakey Heart and Vascular Center, Methodist Hospital, Houston, TX, USA; 3Escuela de Medicina...
Guardado en:
Autores principales: | Ruiz-Esparza GU, Flores-Arredondo JH, Segura-Ibarra V, Torre-Amione G, Ferrari M, Blanco E, Serda RE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb60662a0b1e4134b7edf6a507d6afa9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Particle platforms for cancer immunotherapy
por: Serda RE
Publicado: (2013) -
Industry Platforms as Facilitators of Disruptive IoT Innovations
por: Ionut Pirvan,Cristian, et al.
Publicado: (2019) -
Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
por: Őrfi E, et al.
Publicado: (2019) -
Organization of University Innovative Platforms as a Factor of Development of Competences of Innovative Business
por: Larisa Gennadiyevna Karanatova, et al.
Publicado: (2018) -
Platformization of institutional interactions in the context of stimulating innovations in industry
por: A. I. Shinkevich, et al.
Publicado: (2021)